Curaleaf Holdings (CURLF) Income from Continuing Operations (2019 - 2026)

Curaleaf Holdings (CURLF) recorded quarterly Income from Continuing Operations of 127334000.0 in Q1 2026, down 111.69% quarter-over-quarter from 1089000000.0 in Q4 2025, and down 838.04% on a YoY basis from 17253000.0 in Q1 2025.

Curaleaf Holdings (CURLF) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Curaleaf Holdings' Income from Continuing Operations history runs 8 years deep, the most recent figure standing at 127334000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations fell 838.04% year-over-year to 127334000.0; the TTM figure through Mar 2026 stood at 13127596000.0 (up 5987.05% YoY), while the FY2025 annual figure was 201903000.0, up 4.59% from the prior year.
  • Income from Continuing Operations was 127334000.0 for Q1 2026 at Curaleaf Holdings, down from 1089000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 12160000000.0 in Q2 2025 to a low of 63600000000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 2984202823.53 across 5 years, with a median of 17253000.0 in 2025.
  • The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations tumbled 26884.25% in 2023, then jumped 85359.27% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 235693000.0 in 2022, then sank by 26884.25% to 63600000000.0 in 2023, then soared by 99.57% to 275257000.0 in 2024, then jumped by 495.63% to 1089000000.0 in 2025, then plunged by 111.69% to 127334000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 127334000.0 (Q1 2026), 1089000000.0 (Q4 2025), and 5930000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Curaleaf Holdings - - 157.29 Mn -127.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -127.33 Mn
Dec 31, 2025 1.09 Bn
Sep 30, 2025 5.93 Mn
Jun 30, 2025 12.16 Bn
Mar 31, 2025 17.25 Mn
Dec 31, 2024 -275.26 Mn
Sep 30, 2024 20.78 Mn
Jun 30, 2024 14.23 Mn
Mar 31, 2024 28.60 Mn
Dec 31, 2023 -63.60 Bn
Sep 30, 2023 -4.09 Mn
Jun 30, 2023 17.31 Mn
Mar 31, 2023 -3.15 Mn
Dec 31, 2022 -235.69 Mn
Sep 30, 2022 58.52 Mn
Jun 30, 2022 81.06 Mn
Mar 31, 2022 21.39 Mn
Dec 31, 2021 -5.24 Mn
Sep 30, 2021 62.95 Mn
Jun 30, 2021 76.97 Mn